Internal Medicine, Endocrinology, Diabetes, & Metabolism · Evergreen Park, IL
NPI
1174582811
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
2955 W 95th St
Evergreen Park, IL, 60805
Phone (708) 422-0022
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
4,839 services
Medicare patients, 2024
804
Average age 73
Drug cost, 2024
$4.7M
8,541 prescriptions
Company payments, 2025
$15K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abdallah Altarshan was code 82962 (clinical chemistry), 908 times for 370 patients. In total Abdallah Altarshan billed 4,839 services in 24 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 908 | 370 | $3.19 | $2,895 |
| 99232 Hospital E&M - Subsequent | Facility | 885 | 204 | $64.49 | $57K |
| 83037 Blood Count | Office | 812 | 348 | $9.46 | $7,683 |
| 99213 Office E&M - Established | Office | 704 | 409 | $65.16 | $46K |
| 99214 Office E&M - Established | Office | 462 | 212 | $93.62 | $43K |
| 95251 Test - Miscellaneous | Office | 282 | 119 | $26.43 | $7,452 |
| 99222 Hospital E&M - Initial | Facility | 203 | 178 | $108.12 | $22K |
| 99204 Office E&M - New | Office | 83 | 83 | $132.55 | $11K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 75 | 15 | $3.12 | $234 |
| 76536 Ultrasound - Nonspecific | Office | 55 | 54 | $84.15 | $4,629 |
| 99233 Hospital E&M - Subsequent | Facility | 46 | 20 | $95.49 | $4,393 |
| 96372 Injection Administration | Office | 38 | 23 | $8.26 | $314 |
| 95249 Test - Miscellaneous | Office | 27 | 23 | $52.91 | $1,428 |
| 99212 Office E&M - Established | Office | 16 | 12 | $43.54 | $697 |
| 10005 Other Organ Systems | Office | 15 | 14 | $110.65 | $1,660 |
By year: 2022 $234K for 5,487 services; 2023 $232K for 5,275 services; 2024 $211K for 4,839 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 908 | 370 | $3.19 | $2,895 |
| 83037 Blood Count | 812 | 348 | $9.46 | $7,683 |
Medicare prescription drug claims, 2024
In 2024, the drug Abdallah Altarshan prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,047 prescriptions and refills. In total Abdallah Altarshan wrote 8,541 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,047 | 1,492 | 204 | $1.4M |
| Metformin Hcl Generic | 643 | 1,471 | 186 | $5,433 |
| Jardiance Empagliflozin | 446 | 711 | 97 | $413K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 389 | 781 | 111 | $59K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 325 | 638 | 119 | $32K |
| Levothyroxine Sodium Generic | 301 | 746 | 90 | $3,723 |
| Glipizide Generic | 249 | 566 | 67 | $1,792 |
| Humalog Kwikpen U-100 Insulin Lispro | 243 | 460 | 75 | $70K |
| Tresiba Flextouch U-100 Insulin Degludec | 213 | 412 | 67 | $117K |
| Januvia Sitagliptin Phosphate | 211 | 330 | 46 | $175K |
| Methimazole Generic | 211 | 371 | 46 | $1,989 |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 187 | 249 | 35 | $198K |
| Trulicity Dulaglutide | 172 | 205 | 33 | $196K |
| Mounjaro Tirzepatide | 160 | 188 | 33 | $194K |
| Novolog Flexpen Insulin Aspart | 157 | 299 | 57 | $42K |
Brand drugs: 4,613 claims; generic drugs: 2,837 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abdallah Altarshan $15K ($15K in general payments such as food, travel and fees) from 33 companies. The largest payer was Novo Nordisk Inc with $12K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $12K |
| Insulet Corporation PODD | 5 | $383 |
| Amgen Inc. AMGN | 11 | $286 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $271 |
| Xeris Pharmaceuticals, Inc. | 11 | $259 |
| Recordati_rare_diseases_inc. | 8 | $242 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $148 |
| Abbott Laboratories ABT | 1 | $109 |
| Mannkind Corporation MNKD | 4 | $91.91 |
| Sequel Med Tech, LLC | 3 | $81.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.